Comparison of liver regeneration after a splenectomy and splenic artery ligation in a dimethylnitrosamine-induced cirrhotic rat model

HPB

Volumn 12, Issue 1, 2010, Pages 22-30

  Morinaga, Akio ^a   Ogata, Toshiro ^a   Kage, Masayosi ^a   Kinoshita, Hisafumi ^a   Aoyagi, Sigeaki ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Liver cirrhosis; Liver regeneration; Spleen; Splenectomy; Splenic arterial ligation; TGF 1

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; DIMETHYLNITROSAMINE; KI 67 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; LABELING INDEX; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER REGENERATION; MALE; NONHUMAN; PORTAL VEIN; RAT; SPLEEN ARTERY; SPLENECTOMY;

EID: 75449093826     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00116.x     Document Type: Article

References (31)

1. Akahoshi T, Hashizume M, Tanoue K, Shimabukuro R, Gotoh N, Tomikawa M et al. (2002) Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1. J Gastroenterol Hepatol 17:59-65.
2. Tomikawa M, Hashizume M, Higashi H, Ohta M, Sugimachi K. (1996) The role of the spleen, platelets, and plasma hepatocyte growth factor activity on hepatic regeneration in rats. J Am Coll Surg 182:12-16.
3. Sato K, Tanaka M, Tanikawa K. (1995) The effect of spleen volume on liver regeneration after hepatectomy - A clinical study of liver and spleen volumes by computed tomography. Hepatogastroenterology 42:961-965.
4. Shimada M, Hashizume M, Shirabe K, Takenaka K, Sugimachi K. (2000) A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism. Surg Endosc 14:127-130.
5. Sugawara Y, Yamamoto J, Shimada K, Yamasaki S, Kosuge T, Takayama T et al. (2000) Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg 190:446-450.
6. Ogata T, Okuda K, Morinaga A, Yoshida A, Yasunaga M, Sato H et al. (2005) Treatment for portal hypertension in liver cirrhosis with massive splenomegaly - effect of splenectomy. JPN J Portal Hypertens 11:249-254.
7. Murata K, Shiraki K, Sugimoto K, Takase K, Nakano T, Furusaka A et al. (2001) Splenectomy enhances liver regeneration through tumor necrosis factor following dimethylnitrosoamine induced cirrhotic rat model. Hepatogastroenterology 48:1022-1027.
8. Sato Y, Kobayashi T, Nakatsuka H, Yamamoto S, Oya H, Watanabe T et al. (2001) Splenic arterial ligation prevents liver injury after a major hepatectomy by a reduction of surplus portal hypertension in hepatocellular carcinoma patients with cirrhosis. Hepatogastroenterology 48:831-835.
9. Shimada M, Ijichi H, Yonemura Y, Harada N, Shiotani S, Ninomia M et al. (2004) The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft. Hepatogastroenterology 51:625-629.
10. Ito T, Kiuchi T, Yamamoto H, Oike F, Ogura Y, Fujimoto Y et al. (2003) Changes in portal venous pressure in the early phase after living-donor liver transplantation: pathogenesis and clinical implications. Transplantation 75:1313-1317.
11. Jezequel AM, Mancini R, Rinaldesi ML, Macarri G, Venturini C, Orlandi F. (1987) A morphological study of the early stage of hepatic fibrosis induces by low doses of dimethylnitrosamine in the rat. J Hepatol 5:174-181.
12. Jenkins SA, Grandison A, Bazter JN, Day DW, Taylor I, Shields R. (1985) A Dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat. J Hepatol 1:489-499.
13. Coombs DW, Colburn RW, Deleo JA, Hoopes PJ, Twitchell BB. (1994) Comparative histopathology of epidural hydrogel and silicone elastomer catheters following 30 and 180 days implant in the eye. Acta Anaesthesiol Scand 38:388-395.
14. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H. (2000) Inhibition of transforming growth factor-ß prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 32:247-255.
15. Perez TR. (1983) Is cirrhosis of the liver experimentally produced by CCl4 an adequate model of human cirrhosis? Hepatology 3:112-120.
16. Perez TR, Romero R. (1958) Role of the spleen in regeneration of the liver. Lab Invest 3:248-120.
17. Ono M, Miyamura M, Kyotani S, Saibara T, Ohnishi S, Nishioka Y. (2000) Effect of sho-saiko-to extract on HGF and TGF-ß levels of intraorgans in liver-injured rats after partial hepatectomy. J Pharm Pharmacol 52:111-118.
18. Ueda S, Yamanoi A, Hishikawa Y, Dhar DK, Tachibana M, Nagasue N. (2003) Transforming growth factor-beta1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats. Lab Invest 83:1595-1603.
19. Friedman SL, Flier JS, Underhill LH. (1993) The cellular basis of hepatic fibrosis mechanisms and treatment strategies. N Engl J Med 328:1828-1835.
20. Sanchez A, Alvarez A, Bentio M, Fabregat I. (1996) Apoptosis induced by trans forming growth factor-ß1 in fetal hepatocyte primary cultures. J Biol Chem 271:7416-7422.
21. Carr BI, Hayashi I, Branum EL, Moses HL. (1986) Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type ß transforming growth factor. Cancer Res 46:2330-2334.
22. Qi Z, Atsuchi N, Ooshima A, Takeshita A, Ueno H. (1999) Blockade of type ß transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA 96:2345-2349.
23. Friedman SL, Bansal MB. (2006) Reversal of hepatic fibrosis - fact or fantasy? Hepatology 43:82-88.
24. Nakamura T, Ueno T, Sakamoto M, Sakata R, Torimura T, Hashimoto O et al. (2004) Suppression of transforming growth factor-ß results in upregulation of transcription of regeneration factors after chronic liver injury. J Hepatol 41:974-982.
25. Wakefield H, Winokur TS, Hollands RS, Christopherson K, Levinson AD, Sporn MB. (1976) Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 86:1976-1984.
26. Roberts AB. (1998) Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24:111-119.
27. Witte CL, Corrigan JJ. (1976) Splenic arterial ligation in experimental hypersplenism. Surg Gynecol Obstet 142:1-12.
28. Sato Y, Shimoda S, Takeda N, Tanaka N, Hatakeyama K. (2000) Evaluation of splenic circulation after spleen-preserving distal pancreatectomy by dividing the splenic artery and vein. Dig Surg 17:519-522.
29. Kage M, Shimamatu K, Nakashima E, Kojiro M, Inoue O. (1997) Longterm evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology 25:1028-1031.
30. Kaido T, Oe H, Yoshikawa A, Okajima A, Imamura M. (2004) Expression of molecules associated with hepatocyte growth factor activation after hepatectomy in liver cirrhosis. Hepatogastroenterology 51:547-551.
31. Nagasue N, Dhar DK, Yamanoi A, Emi Y, Udagawa J, Yamamoto A et al. (2000) Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis. Hepatology 31:1107-1114.